Gaming and Leisure Properties, Inc. Announces Fourth Quarter and Full Year 2017 Results
Feb 08, 2018 12:00 pm UTC| Business
- Establishes 2018 First Quarter and Full Year Guidance -- Declares 2018 First Quarter Dividend of $0.63 per Common Share - WYOMISSING, Pa., Feb. 08, 2018 -- Gaming and Leisure Properties, Inc. (NASDAQ:GLPI) (the...
Edge Therapeutics to Present at Upcoming Investor Conferences in February
Feb 08, 2018 12:00 pm UTC| Business
BERKELEY HEIGHTS, N.J., Feb. 08, 2018 -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies for the management of acute, life-threatening conditions,...
Ultralife Corporation Reports Fourth Quarter Results
Feb 08, 2018 12:00 pm UTC| Business
NEWARK, N.Y., Feb. 08, 2018 -- Ultralife Corporation (NASDAQ:ULBI) reported operating income of $2.1 million on revenue of $22.5 million for the fourth quarter ended December 31, 2017 compared to operating income of...
Feb 08, 2018 12:00 pm UTC| Business
LATHAM, N.Y., Feb. 08, 2018 -- Plug Power Inc. (NASDAQ:PLUG), a leader in providing clean, reliable energy solutions, announces the Company will host a business update conference call today, February 8, 2018. On this...
PinkCherry Announces America’s Sexiest Cities
Feb 08, 2018 12:00 pm UTC| Business
LAS VEGAS, Feb. 08, 2018 -- PinkCherry, celebrating their 10 year anniversary, has released their annual list of cities with the highest per person purchases on their American e-commerce site. This year PinkCherry...
Feb 08, 2018 12:00 pm UTC| Business
CHICAGO, Feb. 08, 2018 -- Short-term rentals have caused major disruptions to the apartment industry, sometimes resulting in evictions, lawsuits and even regulatory changes. TransUnion (NYSE:TRU) today announced it has...
Proteostasis Therapeutics to Present at the LEERINK Partners 7th Annual Global Healthcare Conference
Feb 08, 2018 12:00 pm UTC| Business
CAMBRIDGE, Mass., Feb. 08, 2018 -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis...